SciTransfer
Organization

AMBROSIALAB SRL

Italian SME bridging nanomaterial safety informatics and bio-based nanocomposite development for packaging, textile, and automotive industries.

Technology SMEmanufacturingITSMENo active H2020 projectsThin data (2/5)
H2020 projects
2
As coordinator
0
Total EC funding
€241K
Unique partners
48
What they do

Their core work

AMBROSIALAB is an Italian technology SME based in Ferrara specializing in nanomaterial safety science and bio-based polymer nanocomposites. Their work sits at the intersection of computational nanosafety and applied materials science: they contribute nano-informatics tools and exposure assessment methods to evaluate whether nanomaterials are safe by design before they reach industrial production. In parallel, they work on developing and testing nano-enabled bio-based materials — bionanocomposites intended for real industrial end-uses such as packaging, textiles, and automotive parts. Their dual competence in safety assessment methodology and material application testing makes them a specialist partner in EU projects that need both regulatory credibility and industrial relevance.

Core expertise

What they specialise in

Nanomaterial safe-by-design assessmentprimary
1 project

SbD4Nano (2020–2024) involved AMBROSIALAB in building computing infrastructure for defining and performance-testing safe-by-design approaches for nanomaterials.

Nano-informatics and exposure modellingprimary
1 project

SbD4Nano keywords include nano-informatics, data-sharing, and exposure — indicating a computational and data-driven approach to nanomaterial risk characterisation.

Bio-based polymer nanocompositesprimary
1 project

BIONANOPOLYS (2021–2024) focused on developing safe nano-enabled bio-based materials and polymer bionanocomposites within an open innovation test bed framework.

Industrial application testing (packaging, textile, automotive)secondary
1 project

BIONANOPOLYS targeted packaging, textile, non-woven, and automotive sectors as end-use application areas for nano-enabled bio-based materials.

Data sharing and open innovation infrastructuresecondary
2 projects

Both projects involve open-access infrastructure elements — data-sharing platforms in SbD4Nano and an open innovation test bed in BIONANOPOLYS.

Evolution & trajectory

How they've shifted over time

Early focus
Nano-informatics and safe-by-design
Recent focus
Bio-based nanocomposites for industry

AMBROSIALAB entered H2020 with a clear computational nanosafety focus — their first project centred on nano-informatics, exposure modelling, and safe-by-design frameworks, suggesting a background in regulatory science or computational chemistry. Their second project shifted toward the materials side of the same domain: instead of assessing whether nanomaterials are safe, they moved into actually producing bio-based nanocomposites and testing them for industrial markets like packaging and automotive. The trajectory is a natural maturation — from safety tools and methodology toward applying those safety principles in real material development — positioning them as a bridge between nanosafety compliance and industrial material innovation.

AMBROSIALAB appears to be moving from pure safety assessment methodology toward applied material development, making them an increasingly relevant partner for industrial actors who need both compliant and market-ready nano-enabled materials.

Collaboration profile

How they like to work

Role: specialist_contributorReach: European15 countries collaborated

AMBROSIALAB has participated exclusively as a consortium partner, never as project coordinator — a pattern consistent with a specialist SME that brings specific technical capabilities to large multi-partner projects rather than initiating and managing them. Both their projects are large European consortia (one RIA, one IA), meaning they are accustomed to working within complex, multi-institutional environments with clearly defined task contributions. Their 48 unique partners across 15 countries from just two projects indicates they have joined well-networked, pan-European initiatives, broadening their contact base significantly relative to their size.

Despite having only two projects, AMBROSIALAB has connected with 48 unique partners across 15 countries — an unusually broad network for a micro-SME, reflecting their participation in large, internationally diverse consortia. Their network spans primarily European partners, consistent with the H2020 programme's geographic spread.

Why partner with them

What sets them apart

AMBROSIALAB occupies a rare niche: an SME that combines computational nanosafety expertise (nano-informatics, exposure modelling, safe-by-design frameworks) with hands-on bio-based material development and testing. Most nanosafety actors are either academic groups running models or industrial labs focused on production — AMBROSIALAB appears to bridge both. For consortium builders, they offer the credibility of a dedicated safety-science partner alongside practical industrial application experience in packaging, textile, and automotive materials, making them particularly valuable in projects that must satisfy both regulatory and market requirements.

Notable projects

Highlights from their portfolio

  • BIONANOPOLYS
    Largest project by EC contribution (€128,398) and broadest industrial scope — simultaneously targeting packaging, textile, non-woven, and automotive sectors under an open innovation test bed model, demonstrating AMBROSIALAB's ability to contribute to multi-market material development.
  • SbD4Nano
    Signals AMBROSIALAB's foundational competence in computational nanosafety infrastructure, a high-priority regulatory area as EU chemicals legislation tightens around engineered nanomaterials.
Cross-sector capabilities
Digital (nano-informatics platforms, data-sharing infrastructure)Environment (nanomaterial risk and exposure assessment for regulatory compliance)Food (bio-based packaging materials with nanosafety credentials)
Analysis note: Only two projects are available, both started in 2020–2021 and running to 2024, so the early/recent keyword split reflects project sequence rather than a multi-year longitudinal trend. The profile is internally consistent but should be treated as indicative rather than definitive. No website or additional public information was available to cross-validate the scope of AMBROSIALAB's actual laboratory or commercial activities.
More in Manufacturing & Industry 4.0
See all Manufacturing & Industry 4.0 organizations